Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.4097
Delayed Data
As of Feb 05
 +0.0098 / +2.45%
Today’s Change
0.33
Today|||52-Week Range
0.62
-2.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization25.2K30.0K37.0K38.0K
 
 
 
 
 
 
Operating ExpensesGross Income-25.2K-30.0K-37.0K-38.0K
 
 
 
 
 
General Expenses7.3M9.6M10.1M9.8M
 
 
 
 
 
Research And Development4.9M6.0M7.7M7.3M
 
 
 
 
 
Total Operating Expenses7.4M9.7M10.2M9.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.4M-9.7M-10.2M-9.8M
 
 
 
 
 
Extraordinary Credit307.000.000.000.00
 
 
Interest Expense On Debt--0.001.0K101.0K
 
 
 
Other Expenses21.9K4.0K-1.0K-15.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-9.6M-10.2M-9.9M
 
 
 
 
 
Net Income-7.3M-9.6M-10.2M-9.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS145.3M159.5M162.1M163.6M
 
 
 
 
 
Shares To Calculate EPS Diluted145.3M159.5M162.1M163.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.06-$0.06-$0.06
 
 
 
 
 
EPS Diluted-$0.05-$0.06-$0.06-$0.06